ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 17: Congenital malformations and chromosomal abnormalitiesQ81

Q81

Billable

Epidermolysis bullosa

Chapter 17:Congenital malformations and chromosomal abnormalities

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/11/2025

Code Description

ICD-10 Q81 is a billable code used to indicate a diagnosis of epidermolysis bullosa.

Key Diagnostic Point:

Epidermolysis bullosa (EB) is a group of rare genetic disorders characterized by fragile skin that blisters easily in response to minor injury, friction, or even spontaneously. The condition is caused by mutations in genes responsible for the production of proteins that provide structure and stability to the skin. There are several types of EB, including simplex, junctional, and dystrophic, each varying in severity and associated complications. Patients with EB may experience recurrent blistering, scarring, and in severe cases, complications such as infections, nutritional deficiencies, and squamous cell carcinoma. Management of EB often requires a multidisciplinary approach, including dermatology, wound care, nutrition, and sometimes surgical interventions. Genetic counseling is also crucial for affected families to understand inheritance patterns and risks for future pregnancies. The complexity of EB lies in its varied presentations and the need for tailored treatment plans based on the specific type and severity of the condition.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Variety of EB types with different coding implications
  • Need for precise documentation of clinical presentation
  • Potential for associated comorbidities requiring additional codes
  • Genetic testing results influencing coding decisions

Audit Risk Factors

  • Inadequate documentation of the specific type of EB
  • Failure to capture associated complications or comorbidities
  • Misuse of codes for related skin conditions
  • Inconsistent coding across different healthcare providers

Specialty Focus

Medical Specialties

Pediatrics

Documentation Requirements

Detailed history of skin lesions, family history of EB, and treatment plans.

Common Clinical Scenarios

Pediatric patients presenting with blistering skin lesions, requiring wound care and nutritional support.

Billing Considerations

Consideration of growth and development impacts due to chronic skin conditions.

Genetics

Documentation Requirements

Genetic testing results, family pedigree, and inheritance patterns.

Common Clinical Scenarios

Genetic counseling sessions for families with a history of EB, discussing risks for future children.

Billing Considerations

Understanding the implications of genetic mutations on prognosis and management.

Coding Guidelines

Inclusion Criteria

Use Q81 When
  • Follow the official ICD
  • CM guidelines for coding congenital conditions, ensuring specificity in the type of EB and associated complications
  • Document all relevant clinical findings and treatment plans

Exclusion Criteria

Do NOT use Q81 When
No specific exclusions found.

Related CPT Codes

97597CPT Code

Debridement, open wound

Clinical Scenario

Used for managing chronic wounds in EB patients.

Documentation Requirements

Document the extent of debridement and wound assessment.

Specialty Considerations

Pediatric specialists may need to coordinate with wound care teams.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of epidermolysis bullosa, enabling better tracking of the condition and its variants, which aids in research and treatment planning.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of epidermolysis bullosa, enabling better tracking of the condition and its variants, which aids in research and treatment planning.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of epidermolysis bullosa, enabling better tracking of the condition and its variants, which aids in research and treatment planning.

Resources

Clinical References

  • •
    Epidermolysis Bullosa Research Association

Coding & Billing References

  • •
    Epidermolysis Bullosa Research Association

Frequently Asked Questions

What is the importance of genetic testing in epidermolysis bullosa?

Genetic testing is crucial for confirming the diagnosis of epidermolysis bullosa, determining the specific type, and guiding treatment options. It also provides valuable information for family planning and understanding inheritance patterns.